Merck initiates trial for MK-1045 in lupus and rheumatoid arthritis patients
Merck Sharp & Dohme LLC is conducting a clinical study to evaluate the safety and tolerability of MK-1045 in patients with lupus and rheumatoid arthritis.
Asset / Drug
Drug and asset intelligence for MK-1045 with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.